Newron Pharmaceuticals S.p.A., IT0004147952

Newron Pharmaceuticals S.p.A. / IT0004147952

17.06.2024 - 10:16:11

Newron Pharmaceuticals S.p.A.: Dr. Ulrich Köstlin, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

17.06.2024 / 10:14 CET/CEST
The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title:	Dr.
First name:	Ulrich
Last name(s):	Köstlin

2. Reason for the notification

a) Position / status

Position:

Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Newron Pharmaceuticals S.p.A.

b) LEI

8156002F8C11F80A9740

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Share
ISIN:	IT0004147952

b) Nature of the transaction

Acquisition

c) Price(s) and volume(s)

Price(s)	Volume(s)
10.20 EUR	10200.00 EUR
10.24 EUR	10240.00 EUR

d) Aggregated information

Price	Aggregated volume
10.2200 EUR	20440.0000 EUR

e) Date of the transaction

14/06/2024; UTC+2

f) Place of the transaction

Name:	Xetra
MIC:	XETR

17.06.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com